Although heightened GSK3 activity is not the primary cause of disease in this scenario, increased GSK3 activity would serve to augment Aβ production and in turn tau hyper-phosphorylation and neuronal degeneration in both FAD and sporadic cases, in line with the amyloid cascade hypothesis of AD. The gene discussed is MAPT; the disease is Alzheimer disease.